Affiliation:
1. Department of Chemistry and Chemical Engineering Chalmers University of Technology Kemivägen 10 SE-41296 Gothenburg Sweden.
2. Cell Gene and RNA Therapy Discovery Science BioPharmaceuticals R&D AstraZeneca Pepparedsleden 1 431 50 Gothenburg Sweden
Abstract
AbstractFluorescent base analogues (FBAs) have become useful tools for applications in biophysical chemistry, chemical biology, live‐cell imaging, and RNA therapeutics. Herein, two synthetic routes towards a novel FBA of uracil named qU (quadracyclic uracil/uridine) are described. The qU nucleobase bears a tetracyclic fused ring system and is designed to allow for specific Watson‐Crick base pairing with adenine. We find that qU absorbs light in the visible region of the spectrum and emits brightly with a quantum yield of 27 % and a dual‐band character in a wide pH range. With evidence, among other things, from fluorescence lifetime measurements we suggest that this dual emission feature results from an excited‐state proton transfer (ESPT) process. Furthermore, we find that both absorption and emission of qU are highly sensitive to pH. The high brightness in combination with excitation in the visible and pH responsiveness makes qU an interesting native‐like nucleic acid label in spectroscopy and microscopy applications in, for example, the field of mRNA and antisense oligonucleotide (ASO) therapeutics.
Funder
Stiftelsen för Strategisk Forskning
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献